WHY IT MATTERS: If state-level hemp restrictions eliminate access to full-spectrum CBD oils, patients with conditions like Dystonia who have found relief with these specific formulations may be left without a viable therapeutic option and no equivalent substitute. CLINICAL OVERVIEW: Dystonia is a neurological movement disorder characterized by sustained or repetitive muscle contractions that cause abnormal postures and significant pain, and some patients have found meaningful symptom relief through full-spectrum CBD formulations that include a range of naturally occurring cannabinoids beyond CBD alone. The endocannabinoid system plays a role in modulating pain signaling, muscle tone, and neurological function, which provides a plausible biological basis for why patients with movement disorders may respond to cannabinoid-based therapies.